Lupin’s arm -- Lupin Pharmaceuticals Inc. is recalling 2,724 bottles of Clomipramine hydrochloride Capsules USP, 25 mg in the US due to Failed Impurities/Degradation Specifications. This is an antidepressant medication which used in the treatment of obsessive-compulsive disorder. The company initiated the Class II recall on April 18, 2025.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
